Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Taurine and Reduced Fasting Blood Glucose Levels

Research synthesisModerate evidenceSmall effect3 studies · 3 beneficial · 0 neutral · 0 harmful

Across 3 meta-analyses, all 3 reported statistically significant beneficial effects on fasting blood glucose, with effect sizes ranging from small to moderate. The most commonly studied dose was 3 g/day, and effects were observed in diverse populations including general adults, overweight/obese individuals, and those with long COVID. Study durations varied, with one trial lasting 5 days.

  • Effective dose range: 3 g/day (range 0.5–6 g/day)
  • Studied populations: adults with overweight/obesity and those with long COVID (post-acute sequelae of SARS-CoV-2 infection)

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Study durations were not consistently reported, limiting assessment of time to effect. No specific supplement form was identified across studies.

Generated Jul 12, 2026
Doses used in studies
  • g/day: 0.5–6 (median 3.13, IQR 1.135.25) 2 studies
  • mg/day: 3,000 (median 3,000, IQR 3,0003,000) 1 study
Time to effect
Median: 5 days · IQR 5 days5 days · Range 5 days5 days — Reported in 1 of 3 studies
Safety in these studies
3 of 3 papers
Back to top